Adicet reveals Phase 1 data for lupus therapy; Arcus’ ‘best-in-class’ kidney cancer drugnews2025-10-07T14:16:05+00:00October 7th, 2025|Endpoints News|
Women CEOs in biopharma: Gender diversity, pay analysisnews2025-10-07T13:48:28+00:00October 7th, 2025|Endpoints News|
Eli Lilly earmarks $1B to boost India manufacturing footprintnews2025-10-07T12:59:35+00:00October 7th, 2025|Endpoints News|
Biomea shares early Phase 2 diabetes data from repurposed cancer candidatenews2025-10-07T11:09:43+00:00October 7th, 2025|Endpoints News|
AeroRx closes $21M Series A in bid to capitalize on COPD momentumnews2025-10-07T11:00:17+00:00October 7th, 2025|Endpoints News|
Post-Hoc Live: Vijay Pande talks AI bio, starting new fund VZVC after a16znews2025-10-07T11:00:09+00:00October 7th, 2025|Endpoints News|
AstraZeneca’s hypertension pill scores second late-stage winnews2025-10-07T09:25:13+00:00October 7th, 2025|Endpoints News|
MapLight eyes $227M IPO as biopharma market warms upnews2025-10-07T05:10:35+00:00October 7th, 2025|Endpoints News|
Amgen joins Trump’s DTC push, will offer discounted Repathanews2025-10-06T19:00:58+00:00October 6th, 2025|Endpoints News|
FDA to rework ‘CERSI’ university collaborations, will make funding changesnews2025-10-06T17:06:20+00:00October 6th, 2025|Endpoints News|
